C07C 217/60
Linked by carbon chains having two carbon atoms between the amino groups
Official title: linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
C07C217/60 (Linked by carbon chains having two carbon atoms between the amino groups) appears on 222 US grants and 198 published applications in this corpus.
Search patents in C07C- Granted patents
- 222
- Published applications
- 198
- Assignees
- 152
- Inventors
- 655
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 7 | 0 |
| 1992 | 6 | 0 |
| 1993 | 8 | 0 |
| 1994 | 5 | 0 |
| 1995 | 9 | 0 |
| 1996 | 8 | 0 |
| 1997 | 10 | 0 |
| 1998 | 5 | 0 |
| 1999 | 6 | 0 |
| 2000 | 12 | 0 |
| 2001 | 8 | 3 |
| 2002 | 8 | 4 |
| 2003 | 7 | 10 |
| 2004 | 8 | 13 |
| 2005 | 5 | 7 |
| 2006 | 5 | 12 |
| 2007 | 8 | 7 |
| 2008 | 11 | 8 |
| 2009 | 2 | 10 |
| 2010 | 4 | 7 |
| 2011 | 7 | 4 |
| 2012 | 5 | 7 |
| 2013 | 3 | 7 |
| 2014 | 5 | 6 |
| 2015 | 8 | 6 |
| 2016 | 5 | 10 |
| 2017 | 6 | 6 |
| 2018 | 3 | 8 |
| 2019 | 7 | 4 |
| 2020 | 7 | 5 |
| 2021 | 2 | 4 |
| 2022 | 4 | 7 |
| 2023 | 2 | 12 |
| 2024 | 5 | 12 |
| 2025 | 5 | 13 |
| 2026 | 5 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- 5-methoxymethyl and 5-hydroxymethyl phenethylamines28 Jul 2026US 12,692,221 B22A Biosciences, Inc.
- Indane-, indene-, azaindane-, and azaindene-amines as activators of serotonin receptors26 May 2026US 12,636,266 B2Rivo Bio, Inc.
- Phenethylamine derivatives, compositions, and methods of use19 May 2026US 12,630,504 B2Cybin IRL Limited
- Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic/psychotomimetic dosages and formulations5 May 2026US 12,616,706 B2Arbormentis LLC
- Phenalkylamines and methods of treating mood disorders27 Jan 2026US 12,534,425 B2Gilgamesh Pharmaceuticals, Inc.
- Substituted alpha-ethyl phenylalkylamines13 Aug 2026US 2026/0232606 A1Alexander Shulgin Research Institute, Inc.
- Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic / psychotomimetic dosages and formulations13 Aug 2026US 2026/0232704 A1Arbormentis LLC
- Small molecule drugs and related methods for treatment of diseases related to ab42 oligomer formation25 Jun 2026US 2026/0176230 A1Acelot, Inc.
- Substituted phenylalkylamines18 Jun 2026US 2026/0165986 A1Alexander Shulgin Research Institute, Inc.
- Phenethylamine derivatives, compositions, and methods of use18 Jun 2026US 2026/0167603 A1Cybin IRL Limited
Most cited
By later US patents
- Sigma receptor ligands and the use thereof150US 6,057,371 AVirginia Commonwealth University · 2000
- Calcium receptor-active molecules72US 6,031,003 ANPS Pharmaceuticals, Inc. · 2000
- Calcium receptor-active molecules67US 6,011,068 ANPS Pharmaceuticals, Inc. · 2000
- Use of .alpha..sub.1C specific compounds to treat benign prostatic hyperlasia53US 5,403,847 ASynaptic Pharmaceutical Corporation · 1995
- Aryl substituted nitrogen heterocyclic antidepressants49US 5,128,358 APfizer Inc. · 1992